UBS ASSET MANAGEMENT AMERICAS LLC - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$5,516,816
-26.2%
133,741
-0.2%
0.00%
-50.0%
Q2 2023$7,478,1480.0%134,0410.0%0.00%0.0%
Q1 2023$7,478,148
+59.7%
134,041
+4.3%
0.00%
+100.0%
Q4 2022$4,682,357
-99.9%
128,495
-0.8%
0.00%0.0%
Q3 2022$3,688,531,000
-82.3%
129,513
-71.8%
0.00%
-81.8%
Q2 2022$20,785,226,000
-50.7%
459,342
-17.2%
0.01%
-38.9%
Q1 2022$42,200,061,000
-43.0%
554,753
+11.6%
0.02%
-35.7%
Q4 2021$74,052,334,000
-3.7%
497,129
-5.9%
0.03%
-12.5%
Q3 2021$76,907,005,000
-24.2%
528,280
+2.0%
0.03%
-25.6%
Q2 2021$101,425,556,000
+12.6%
517,953
+4.1%
0.04%
+7.5%
Q1 2021$90,086,234,000
+2.4%
497,714
-19.9%
0.04%
-2.4%
Q4 2020$87,948,892,000
+60.1%
621,108
+41.0%
0.04%
+36.7%
Q3 2020$54,925,405,000
+55.5%
440,531
+11.4%
0.03%
+36.4%
Q2 2020$35,311,476,000
+56.1%
395,381
+8.9%
0.02%
+37.5%
Q1 2020$22,621,663,000
-18.2%
362,992
+0.1%
0.02%
-5.9%
Q4 2019$27,639,635,000
+196.9%
362,487
+96.3%
0.02%
+183.3%
Q3 2019$9,308,023,000184,6830.01%
Other shareholders
10X GENOMICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders